Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 114 results:
Συντάκτης Τίτλος Τύπος [ Έτος(Asc)]
Φίλτρα: Συντάκτης is Doumas, Michael  [Clear All Filters]
2016
Boutari, C., Stavropoulos K., Imprialos K. P., Petidis K., & Doumas M. (2016).  Antihypertensive Drug-Related Side Effects: Is It the Unique Indicator for Nonadherence?. Am J Hypertens. 29(5), 662.
Imprialos, K. P., Boutari C., Stavropoulos K., Doumas M., Athyros V. G., & Karagiannis A. I. (2016).  Current challenges in antihypertensive treatment in the elderly.. Pol Arch Med Wewn. 126(7-8), 540-51.
Imprialos, K., Boutari C., Stavropoulos K., Doumas M., & Karagiannis A. I. (2016).  Depression in hypertensive patients: the role of comorbidities.. J Hypertens. 34(7), 1441.
Athyros, V. Gabriel, Doumas M., & Karagiannis A. (2016).  Differential residual dyslipidemia/cardiovascular risk after statin treatment between Asian-Indians and western whites. Call for action.. Indian Heart J. 68(5), 596-598.
Imprialos, K., Boutari C., & Doumas M. (2016).  Discontinuation of Antihypertensive Treatment in Elderly Patients and Cognitive Function.. JAMA Intern Med. 176(3), 409.
Stergiou, G. S., Doumas M., Kollias A., & Papademetriou V. (2016).  Important practice lessons from the SPRINT study beyond the blood pressure goal: all well known and now confirmed.. J Am Soc Hypertens. 10(8), 613-7.
Katsiki, N., Doumas M., & Mikhailidis D. P. (2016).  Lipids, Statins and Heart Failure: An Update.. Curr Pharm Des. 22(31), 4796-4806.
Papademetriou, V., Doumas M., & Tsioufis C. (2016).  Renal Sympathetic Denervation: Hibernation or Resurrection?. Cardiology. 135(2), 87-97.
2015
Doumas, M., Papademetriou V., Athyros V., & Karagiannis A. (2015).  Arterial Stiffness and Emerging Biomarkers: Still a Long Journey to Go.. Angiology. 66(10), 901-3.
Athyros, V. G., Tziomalos K., Katsiki N., Doumas M., Karagiannis A., & Mikhailidis D. P. (2015).  Cardiovascular risk across the histological spectrum and the clinical manifestations of non-alcoholic fatty liver disease: An update.. World J Gastroenterol. 21(22), 6820-34.
Papadopoulou, E., Varouktsi A., Lazaridis A., Boutari C., & Doumas M. (2015).  Erectile dysfunction in chronic kidney disease: From pathophysiology to management.. World J Nephrol. 4(3), 379-87.
Katsiki, N., Doumas M., Athyros V. G., & Karagiannis A. (2015).  Hyperuricemia as a risk factor for cardiovascular disease.. Expert Rev Cardiovasc Ther. 13(1), 19-20.
Kargiotis, K., Athyros V. G., Giouleme O., Katsiki N., Katsiki E., Anagnostis P., et al. (2015).  Resolution of non-alcoholic steatohepatitis by rosuvastatin monotherapy in patients with metabolic syndrome.. World J Gastroenterol. 21(25), 7860-8.
Doumas, M., Athyros V., & Papademetriou V. (2015).  Screening for Primary Aldosteronism: Whom and How?. J Clin Hypertens (Greenwich). 17(7), 547-8.
Doumas, M., Athyros V., & Karagiannis A. (2015).  Transcatheter Renal Sympathetic Denervation: Chasing a Chimera or a Matter of Technological Improvements?. Cardiology. 131(3), 186-8.
2014
Nikolaidou, B., Lazaridis A., & Doumas M. (2014).  Antihypertensive therapy after acute ischemic stroke.. JAMA. 311(22), 2333-4.
Nikolaidou, B., Lazaridis A., & Doumas M. (2014).  Combined angiotensin inhibition in diabetic nephropathy.. N Engl J Med. 370(8), 778-9.
Doumas, M. (2014).  Editorial: interventional management of hypertension and cardiovascular disease: the beginning of a new era?. Curr Vasc Pharmacol. 12(1), 2-3.
Reklou, A., Lazaridis A., Nikolaidou B., Kadiltzoglou P., & Doumas M. (2014).  Macro and microcirculation damage and incident hypertension: predictors of progression?. J Hypertens. 32(5), 1154.
Doumas, M., Tsioufis C., Faselis C., Lazaridis A., Grassos H., & Papademetriou V. (2014).  Non-interventional management of resistant hypertension.. World J Cardiol. 6(10), 1080-90.
Gkaliagkousi, E., Gavriilaki E., Yiannaki E., Markala D., Papadopoulos N., Triantafyllou A., et al. (2014).  Platelet activation in essential hypertension during exercise: pre- and post-treatment changes with an angiotensin II receptor blocker.. Am J Hypertens. 27(4), 571-8.
Katsiki, N., Doumas M., Athyros V. G., & Karagiannis A. (2014).  Prehypertension and the cardiometabolic syndrome: targeting several risk factors to achieve maximum benefit.. Expert Rev Cardiovasc Ther. 12(3), 295-6.

Σελίδες

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.